Drug Shortage Report for BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
| Report ID | 211218 |
| Drug Identification Number | 02460645 |
| Brand name | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP |
| Common or Proper name | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Strength(s) | 7.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRASPINAL INTRASPINAL |
| Packaging size | 10 AMPOULES X 2 ML |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-03-27 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2024-03-08 |
| Shortage status | Avoided shortage |
| Updated date | 2024-03-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-03-08 | French | Compare |
| v4 | 2024-03-08 | English | Compare |
| v3 | 2024-01-22 | English | Compare |
| v2 | 2023-11-22 | French | Compare |
| v1 | 2023-11-22 | English | Compare |
Showing 1 to 5 of 5